357 related articles for article (PubMed ID: 9489805)
1. The OMERACT filter for Outcome Measures in Rheumatology.
Boers M; Brooks P; Strand CV; Tugwell P
J Rheumatol; 1998 Feb; 25(2):198-9. PubMed ID: 9489805
[No Abstract] [Full Text] [Related]
2. [Treatment outcome parameters].
Burmester GR; Smolen J
Z Rheumatol; 2009 Feb; 68(1):9. PubMed ID: 19156433
[No Abstract] [Full Text] [Related]
3. What has been the effect on trial outcome assessments of a decade of patient participation in OMERACT?
de Wit MP; Abma TA; Koelewijn-van Loon MS; Collins S; Kirwan J
J Rheumatol; 2014 Jan; 41(1):177-84. PubMed ID: 24128777
[TBL] [Abstract][Full Text] [Related]
4. OMERACT 6 brings new perspectives to rheumatology measurement research.
Saag KG
J Rheumatol; 2003 Apr; 30(4):639-41. PubMed ID: 12672177
[No Abstract] [Full Text] [Related]
5. OMERACT 10--International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials.
Brooks P; Boers M; Simon LS; Strand V; Tugwell P; Idzerda L
J Rheumatol; 2011 Jul; 38(7):1450-51. PubMed ID: 21724714
[No Abstract] [Full Text] [Related]
6. OMERACT: an international initiative to improve outcome measurement in rheumatology.
Boers M; Brooks P; Simon LS; Strand V; Tugwell P
Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S10-3. PubMed ID: 16273779
[TBL] [Abstract][Full Text] [Related]
7. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.
Boers M; Kirwan JR; Wells G; Beaton D; Gossec L; d'Agostino MA; Conaghan PG; Bingham CO; Brooks P; Landewé R; March L; Simon LS; Singh JA; Strand V; Tugwell P
J Clin Epidemiol; 2014 Jul; 67(7):745-53. PubMed ID: 24582946
[TBL] [Abstract][Full Text] [Related]
8. Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working Party. Outcome Measures in Rheumatology.
Gazarian M; Tugwell P; Boers M; Bombardier C; Brooks P; Day R; Strand V; Wells G
J Rheumatol; 1999 Jan; 26(1):207-9. PubMed ID: 9918265
[TBL] [Abstract][Full Text] [Related]
9. Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group.
Klokker L; Tugwell P; Furst DE; Devoe D; Williamson P; Terwee CB; Suarez-Almazor ME; Strand V; Woodworth T; Leong AL; Goel N; Boers M; Brooks PM; Simon LS; Christensen R
J Rheumatol; 2017 Dec; 44(12):1916-1919. PubMed ID: 27744393
[TBL] [Abstract][Full Text] [Related]
10. [From uncertainty to evidence : modern statistics in rheumatology].
Zink A; Sieper J
Z Rheumatol; 2015 Mar; 74(2):104-5. PubMed ID: 25805511
[No Abstract] [Full Text] [Related]
11. Contributions of OMERACT to rheumatic disease research.
Singh JA; Solomon DH; Dougados M; Felson D; Hawker G; Katz P; Paulus H; Siegel J; Wallace C
Arthritis Rheum; 2007 Feb; 57(1):186. PubMed ID: 17266140
[No Abstract] [Full Text] [Related]
12. Proceedings of OMERACT 10, the International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials. May 4-8, 2010. Kota Kinabalu, Borneo.
J Rheumatol; 2011 Jul; 38(7):1448-518. PubMed ID: 22263235
[No Abstract] [Full Text] [Related]
13. How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.
Boers M; Kirwan JR; Gossec L; Conaghan PG; D'Agostino MA; Bingham CO; Brooks PM; Landewé R; March L; Simon L; Singh JA; Strand V; Wells GA; Tugwell P
J Rheumatol; 2014 May; 41(5):1025-30. PubMed ID: 24584913
[TBL] [Abstract][Full Text] [Related]
14. Patient perspective: choosing or developing instruments.
Kirwan JR; Fries JF; Hewlett S; Osborne RH
J Rheumatol; 2011 Aug; 38(8):1716-9. PubMed ID: 21807791
[TBL] [Abstract][Full Text] [Related]
15. OMERACT 11: international consensus conference on outcome measures in rheumatology.
Simon LS; Strand V; Bingham CO; Singh JA
J Rheumatol; 2014 Jan; 41(1):145-9. PubMed ID: 24382928
[No Abstract] [Full Text] [Related]
16. Patient perspective on outcomes in rheumatology -- a position paper for OMERACT 9.
Kirwan JR; Newman S; Tugwell PS; Wells GA
J Rheumatol; 2009 Sep; 36(9):2067-70. PubMed ID: 19738215
[TBL] [Abstract][Full Text] [Related]
17. Updating the OMERACT filter at OMERACT 11.
Kirwan JR; Boers M; Tugwell P
J Rheumatol; 2014 May; 41(5):975-7. PubMed ID: 24788466
[TBL] [Abstract][Full Text] [Related]
18. Saving time and improving care with a multidimensional health assessment questionnaire: 10 practical considerations.
Pincus T; Yazici Y; Bergman M
J Rheumatol; 2006 Mar; 33(3):448-54. PubMed ID: 16511913
[No Abstract] [Full Text] [Related]
19. [Continuous quick development of rheumatology].
Madsen OR; Terslev L; Tarp U; Jacobsen S; Ostergaard M
Ugeskr Laeger; 2009 Mar; 171(13):1092. PubMed ID: 19321087
[No Abstract] [Full Text] [Related]
20. Methodology for clinical trials in rheumatology: logical foundations.
Cook RJ; Farewell VT; Gladman DD
J Rheumatol; 1997 Oct; 24(10):1861-5. PubMed ID: 9330922
[No Abstract] [Full Text] [Related]
[Next] [New Search]
